Buspirone Hydrochloride Tablet
Product Images NDC 71610-165

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Buspirone Hydrochloride (NDC 71610-165). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aphena Pharma Solutions - Tennessee, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Bottle Label 5 mg (71610 0165 53)

This is a medication description for Buspirone Hydrochloride, USP. It comes in a bottle with 60 tablets, each containing 5mg of the active ingredient. There is also a barcode or product number labeled NOCH 7161001855.*

FDA Label Image

Aphena Pharma Solutions (TN)

FDA Label Image

Dosage Table (Buspirone Fig 1)

This appears to be a set of written dosage instructions for a medication in tablet form. Depending on the dosage prescribed by the doctor, patients are instructed to take different numbers of tablets or partial tablets. Specifically, if the doctor prescribed a 15 mg tablet, the patient should take 1 full tablet (which appears to be labeled as "J4" in the text). If the doctor prescribed a 30 mg tablet, the patient should take 1 full tablet (labeled as "Ts"). For smaller doses, the patient should take partial tablets. For a 10 mg dose, the patient should take 2/3 of a tablet (labeled as "B8"). for a smaller 5 mg dose, the patient should take 1/3 of a tablet (labeled as "g]")*

FDA Label Image

Quadrisect Photo (Buspirone Fig 2)

This is a list of two different dosage strengths of an unnamed medication, one being a 5mg tablet and the other being a 30mg tablet. No further information is available.*

FDA Label Image

Buspirone Structural Formula (Buspirone Str)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.